Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantin Lapa

Showing results (181-190 of 317) with videos related to

Pageof 32
Sort By:
European Heart Journal. Cardiovascular Imaging|August 14, 2018
Longitudinal 18F-FDG PET imaging in a rat model of autoimmune myocarditisRudolf A Werner, Hiroshi Wakabayashi, Jochen Bauer, et al.
Molecular Imaging and Biology|May 4, 2026
Diagnostic Performance of Somatostatin Receptor-directed PET/CT for Tumor-induced OsteomalaciaMarieke Heinrich, Aleksander Kosmala, Alexander Dierks, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 11, 2024
Preclinical evaluation of <sup>225</sup>Ac-labeled minigastrin analog DOTA-CCK-66 for Targeted Alpha TherapyNadine Holzleitner, Meryl Vilangattil, Abir Swaidan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2025
CCK<sub>2</sub> Receptor Ligand [<sup>68</sup>Ga]Ga-DOTA-CCK-66 PET/CT Outperforms [<sup>68</sup>Ga]Ga-DOTATOC PET/CT in a Patient with Small Cell Lung CancerOliver Viering, Nadine Holzleitner, Rainer Claus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2019
Imaging Inflammation in Atherosclerosis with CXCR4-Directed <sup>68</sup>Ga-Pentixafor PET/CT: Correlation with <sup>18</sup>F-FDG PET/CTMalte Kircher, Johannes Tran-Gia, Luisa Kemmer, et al.
Nuklearmedizin. Nuclear Medicine|January 14, 2022
[18F]DCFPyL PET/CT for Imaging of Prostate CancerSteven P Rowe, Andreas Buck, Ralph A Bundschuh, et al.
Clinical Nuclear Medicine|August 2, 2024
Biodistribution and Radiation Dosimetry for 68 Ga-DOTA-CCK-66, a Novel CCK 2 R-Targeting Compound for Imaging of Medullary Thyroid CancerOliver Viering, Andreas Rinscheid, Nadine Holzleitner, et al.
European Journal of Radiology|March 17, 2025
Interpretable machine learning for thyroid cancer recurrence predicton: Leveraging XGBoost and SHAP analysisAndreas Schindele, Anne Krebold, Ursula Heiß, et al.
Oncotarget|February 5, 2016
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experienceConstantin Lapa, Katharina Lückerath, Martina Rudelius, et al.
Neuroendocrinology|September 25, 2025
Gastrointestinal Neuroendocrine Neoplasms in Children and Adolescents: Data from the German MET Studies (1997-2024)Katharina Karges, Marina Kunstreich, Michael Abele, et al.
Pageof 32

Showing results (181-190 of 317) with videos related to

Sort By:
Pageof 32
European Heart Journal. Cardiovascular Imaging|August 14, 2018
Longitudinal 18F-FDG PET imaging in a rat model of autoimmune myocarditisRudolf A Werner, Hiroshi Wakabayashi, Jochen Bauer, et al.
Molecular Imaging and Biology|May 4, 2026
Diagnostic Performance of Somatostatin Receptor-directed PET/CT for Tumor-induced OsteomalaciaMarieke Heinrich, Aleksander Kosmala, Alexander Dierks, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 11, 2024
Preclinical evaluation of <sup>225</sup>Ac-labeled minigastrin analog DOTA-CCK-66 for Targeted Alpha TherapyNadine Holzleitner, Meryl Vilangattil, Abir Swaidan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2025
CCK<sub>2</sub> Receptor Ligand [<sup>68</sup>Ga]Ga-DOTA-CCK-66 PET/CT Outperforms [<sup>68</sup>Ga]Ga-DOTATOC PET/CT in a Patient with Small Cell Lung CancerOliver Viering, Nadine Holzleitner, Rainer Claus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2019
Imaging Inflammation in Atherosclerosis with CXCR4-Directed <sup>68</sup>Ga-Pentixafor PET/CT: Correlation with <sup>18</sup>F-FDG PET/CTMalte Kircher, Johannes Tran-Gia, Luisa Kemmer, et al.
Nuklearmedizin. Nuclear Medicine|January 14, 2022
[18F]DCFPyL PET/CT for Imaging of Prostate CancerSteven P Rowe, Andreas Buck, Ralph A Bundschuh, et al.
Clinical Nuclear Medicine|August 2, 2024
Biodistribution and Radiation Dosimetry for 68 Ga-DOTA-CCK-66, a Novel CCK 2 R-Targeting Compound for Imaging of Medullary Thyroid CancerOliver Viering, Andreas Rinscheid, Nadine Holzleitner, et al.
European Journal of Radiology|March 17, 2025
Interpretable machine learning for thyroid cancer recurrence predicton: Leveraging XGBoost and SHAP analysisAndreas Schindele, Anne Krebold, Ursula Heiß, et al.
Oncotarget|February 5, 2016
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experienceConstantin Lapa, Katharina Lückerath, Martina Rudelius, et al.
Neuroendocrinology|September 25, 2025
Gastrointestinal Neuroendocrine Neoplasms in Children and Adolescents: Data from the German MET Studies (1997-2024)Katharina Karges, Marina Kunstreich, Michael Abele, et al.
Pageof 32